TrialAdvances in respiratory medicine2025
Effectiveness and Safety of Glycopyrronium-Formoterol-Budesonide Triple Therapy in Chronic Obstructive Pulmonary Disease (AIR-FORCE): An Open-Label Multi-Centric Phase 4 Study.
Anjali R Nath et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.